TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 25 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $3,259 | +79.7% | 7,579 | -26.9% | 0.00% | – |
| Q4 2023 | $1,814 | -2.1% | 10,365 | -0.4% | 0.00% | – |
| Q3 2023 | $1,852 | -39.0% | 10,407 | -0.3% | 0.00% | – |
| Q2 2023 | $3,037 | +50516.7% | 10,436 | +211.8% | 0.00% | – |
| Q1 2023 | $6 | -53.8% | 3,347 | -60.7% | 0.00% | -100.0% |
| Q4 2022 | $13 | -99.9% | 8,517 | +24.6% | 0.00% | – |
| Q3 2022 | $11,000 | +266.7% | 6,837 | +322.0% | 0.00% | – |
| Q2 2022 | $3,000 | +200.0% | 1,620 | +518.3% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 262 | -41.1% | 0.00% | – |
| Q3 2021 | $2,000 | -95.6% | 445 | -91.9% | 0.00% | -100.0% |
| Q1 2021 | $45,000 | -66.7% | 5,486 | -52.6% | 0.00% | -75.0% |
| Q4 2020 | $135,000 | +1025.0% | 11,564 | +418.8% | 0.00% | – |
| Q3 2020 | $12,000 | – | 2,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,190,000 | $6,997,000 | 2.89% |
| Ikarian Capital, LLC | 2,765,530 | $4,618,000 | 0.92% |
| Telemetry Investments, L.L.C. | 97,000 | $162,000 | 0.21% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $48,000 | 0.07% |
| JOHNSON & JOHNSON | 84,003 | $140,000 | 0.04% |
| NEA Management Company, LLC | 346,719 | $579,000 | 0.03% |
| X-Square Capital, LLC | 17,973 | $30,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $432,000 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $760,000 | 0.01% |
| DOWLING & YAHNKE LLC | 47,455 | $79,000 | 0.00% |